Stability Testing for Generic Drug Products at a CDMO: ICH Q1A Requirements and ANDA Expectations
Introduction Stability Testing for Generic Drug Products at a CDMO forms the scientific foundation for demonstrating that a generic finished […]
CMC Documentation at a CDMO for ANDA: What Goes Into Sections P and S of the CTD
Introduction CMC documentation at a CDMO for ANDA submissions forms the foundation of regulatory compliance by demonstrating that a generic
CMC Documentation at a CDMO for ANDA: What Goes Into Sections P and S of the CTD Read More »
Intact Mass Analysis and Average Mass Determination for Multi-Chain and Branched Therapeutic Peptides
Introduction Intact Mass Analysis and Average Mass Determination are fundamental techniques used to confirm the primary structure of complex multi-chain
Forced Degradation and Photostability Studies for Generic Drug ANDA Submissions
Introduction Forced Degradation and Photostability Studies for Generic Drug ANDA Submissions form the analytical cornerstone required to demonstrate that a
Forced Degradation and Photostability Studies for Generic Drug ANDA Submissions Read More »
Case Study: Radiolabeled Peptide Manufacturing for a Diagnostic Imaging Program
Introduction Radiolabeled Peptide Manufacturing involves a highly coordinated framework that combines automated solid-phase peptide synthesis, efficient chelator conjugation, and controlled
Case Study: Radiolabeled Peptide Manufacturing for a Diagnostic Imaging Program Read More »
Container Closure Integrity Testing (CCIT) for Generic Sterile Drug Products: CDMO Capabilities and Regulatory Expectations
Introduction Container Closure Integrity Testing (CCIT) for Generic Sterile Drug Products is a critical process used to confirm that a
CDMO Services for Generic Topical and Semisolid Drug Products: Creams, Ointments, and Gel ANDA Development
Introduction CDMO Services for Generic Topical and Semisolid Drug Products provide the specialized formulation development, analytical characterization, and manufacturing capabilities
Bioequivalence Study Design for Complex Generic Drug Products: What the CDMO and Sponsor Must Plan Together
Introduction Bioequivalence study design for complex generic drug products requires a comprehensive and integrated development strategy that combines precise qualitative/quantitative
Outsourcing Extractables and Leachables (E&L) Testing: Why CROs Choose a Health Canada DEL Licensed Lab
Introduction Outsourcing Extractables and Leachables (E&L) Testing to a Drug Establishment License (DEL) holder ensures that analytical data is generated
Case Study: Formulating a Lyophilized Peptide Injectable for Long-Term Stability and Reconstitution
Introduction Formulating a Lyophilized Peptide Injectable involves the strategic design of a solid-state glass matrix capable of maintaining peptide chemical